Clinical Trial: The Safety of Thoracentesis, Tunneled Pleural Catheter, and Chest Tubes in Patients Taking Novel Oral Anti-Coagulants

U.S., Jan. 21 -- ClinicalTrials.gov registry received information related to the study (NCT03535883) titled 'The Safety of Thoracentesis, Tunneled Pleural Catheter, and Chest Tubes in Patients Taking Novel Oral Anti-Coagulants' on May 8, 2018.

Brief Summary: To assess risks of bleeding in those individuals receiving Novel Oral Anti-Coagulant (NOAC) medications, admitted to the hospital and require thoracentesis, chest tube or tunneled pleural catheter placement.

Study Type: Observational

Condition: * Pleural Effusion

* Thoracic Effusion

Intervention: Drug: Novel Oral Anti-Coagulants

Novel Oral Anti-Coagulant (NOAC) medications (i.e. Eliquis, Plavix, Xarelto etc.)

Other Name: NOAC

Recruitment Status: Recruiting

Sponsor: Yale Univers...